XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

Derivative Instruments | 9 Months Ended
--- | ---
Sep. 30, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Derivative Instruments | Note 12 – Derivative Instruments The Company uses derivative instruments, specifically, forward foreign exchange contracts, to manage the risk associated with the volatility of future cash flows. The forward foreign exchange contracts are used to mitigate the impact of exchange rate fluctuations on certain forecasted inventory purchases and are designated as cash flow hedges. The notional amounts of the Company’s outstanding derivative instruments as of September 30, 2025 and December 31, 2024 were as follows:
|  | September 30, 2025 |  | December 31, 2024
Derivative instruments designated as accounting hedges: |  |  |  |
Foreign exchange contracts |  | $ | 109,428 |  |  | $ | 90,031 |
The fair value of the Company’s outstanding derivative instruments as of September 30, 2025 and December 31, 2024 were as follows:
| Balance Sheet Classification |  | September 30, 2025 |  | December 31, 2024
Assets: |  |  |  |  |
Forward contracts | Other current assets |  | $ | 352 |  |  | $ | 2,175 |
Liabilities: |  |  |  |  |
Forward contracts | Other current liabilities |  | $ | 3,062 |  |  | $ | 816 |
The following table presents the pretax impact of gains/(loss) from the Company's designated derivative instruments on its Condensed Consolidated Financial Statements for the periods ended September 30, 2025 and September 30, 2024:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Cash flow hedges: |  |  |  |  |  |  |
Foreign exchange contracts | $ | 1,161 |  |  | $ | (1,039) |  |  | $ | (4,000) |  |  | $ | 482 |
As of September 30, 2025, the current maturity dates of the Company’s derivative instruments range from July 2025 to September 2026. For the periods ended September 30, 2025 and 2024, the Company's hedging activities were deemed effective, with no ineffectiveness recognized in the Condensed Consolidated Statements of Operations. Gains and losses from these hedging activities are recorded in cost of sales in the Condensed Consolidated Statements of Operations. In the second quarter of 2025, the Company settled certain foreign exchange forward contracts that were entered into to hedge foreign exchange rate risk surrounding a portion of the purchase price in connection with the Kurt Geiger acquisition. The settlement resulted in a gain of $9,252, which was recorded as gain on derivative in the Company's Condensed Consolidated Statements of Operations for the nine months ended September 30, 2025.

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for derivatives and fair value of assets and liabilities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 815 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/815/tableOfContent + Details
Name: | us-gaap_DerivativesAndFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration